Articles About AbbVie
April 14, 2014
Merck, Bristol-Myers Squibb, AbbVie, and Gilead Sciences all have hepatitis C cures under development; Gilead's Sovaldi leads, but Merck's drug is competitive.
March 28, 2014
Picking stocks is something best left to those with a generous appetite for risk. For the rest of us, there are exchange-traded funds.